Simplified criteria for the diagnosis of autoimmune hepatitis
暂无分享,去创建一个
K. Boberg | P. Galle | H. Dienes | A. Lohse | A. Czaja | M. Zeniya | C. Schramm | F. Bianchi | A. Parés | E. Krawitt | G. Porta | G. Dalekos | P. Bittencourt | H. Hofer | I. Mcfarlane | B. Torres | M. Shibata | E. Hennes | AnsgarW. Lohse | Barbara Eisenmann de Torres | A. Lohse | Edward L. Krawitt | Peter R. Galle | Paulo L. Bittencourt | Francesco B. Bianchi | P. R. Galle | Paulo L. Bittencourt | Francesco B. Bianchi | Paulo L. Bittencourt | Francesco B. Bianchi | Barbara Eisenmann de Torres
[1] A. Lohse,et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders , 2007, Journal of autoimmune diseases.
[2] P. Galle,et al. Evaluation of F-Actin ELISA for the Diagnosis of Autoimmune Hepatitis , 2006, The American Journal of Gastroenterology.
[3] B. Portmann,et al. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. , 2006, Journal of hepatology.
[4] T. Arenovich,et al. Autoimmune hepatitis: Effect of symptoms and cirrhosis on natural history and outcome , 2005, Hepatology.
[5] E. Ballot,et al. Diagnostic Value of Anti‐F‐Actin Antibodies in a French Multicenter Study , 2005, Annals of the New York Academy of Sciences.
[6] M. Swain,et al. A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful? , 2005, American journal of hematology.
[7] M. Manns,et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. , 2004, Journal of hepatology.
[8] P. Galle,et al. Liver Assessment and Biopsy in Patients With Marked Coagulopathy: Value of Mini-Laparoscopy and Control of Bleeding , 2003, American Journal of Gastroenterology.
[9] J. Herkel,et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics , 2002, Gut.
[10] P. Schirmacher,et al. Autoimmune hepatitis and overlap syndromes. , 2002, Clinics in liver disease.
[11] Mark George Thomas,et al. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease , 2002, Hepatology.
[12] J. Herkel,et al. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas , 2002, Hepatology.
[13] G. Gerken,et al. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. , 2001, Zeitschrift fur Gastroenterologie.
[14] T. Kanematsu,et al. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group. , 2000, Internal medicine.
[15] K. Lindor,et al. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. , 2000, Journal of hepatology.
[16] F. Vleggaar,et al. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. , 2000, Journal of hepatology.
[17] J. Herkel,et al. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis , 2000, The Lancet.
[18] M. Manns,et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.
[19] E. Elias,et al. Recurrence of autoimmune hepatitis after liver transplantation. , 1999, Transplantation.
[20] D. R. Parker,et al. Autoimmune hepatitis in the elderly , 1998, Gut.
[21] G. Gerken,et al. Autoimmune hepatitis and hepatitis C virus infection. , 1998, Current studies in hematology and blood transfusion.
[22] K. Kikuchi,et al. Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis , 1997, Journal of Gastroenterology.
[23] M. Omata,et al. Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. , 1997, Journal of hepatology.
[24] M. Gaffey,et al. The international autoimmune hepatitis score in chronic hepatitis C , 1997, Journal of viral hepatitis.
[25] A. Czaja,et al. Validation of scoring system for diagnosis of autoimmune hepatitis , 1996, Digestive Diseases and Sciences.
[26] G. Gerken,et al. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. , 1995, Zeitschrift fur Gastroenterologie.
[27] P. Johnson,et al. Meeting report: International autoimmune hepatitis group , 1993, Hepatology.
[28] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[29] S. Pocock,et al. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. , 1980, Gut.
[30] L. Elveback,et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.
[31] F. Giostra,et al. Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis , 2005, Digestive Diseases and Sciences.
[32] K. Boberg,et al. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. , 1998, Scandinavian journal of gastroenterology.
[33] N. Mcintyre,et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. , 1993, Journal of hepatology.